LAKESHORE BIOPHARMA CO LTD (LSB) Forecast, Price Target & Analyst Ratings
NASDAQ:LSB • KYG9845F2080
0.627 USD
-0.16 (-20.68%)
At close: Sep 19, 2025
0.5399 USD
-0.09 (-13.89%)
After Hours: 9/19/2025, 8:26:53 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for LAKESHORE BIOPHARMA CO LTD (LSB).
Forecast Snapshot
Consensus Price Target
$31.62
+ 4,943.06% Upside
Next Earnings Forecast
Release DateDec 15, 2025
ChartMill Buy Consensus
80.00%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
$31.62
Upside
+ 4,943.06%
From current price of $0.63 to mean target of $31.62, Based on 5 analyst forecasts
Low
$31.31
Median
$31.62
High
$32.55
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
5 Wall Street analysts provided a forecast for the next 12 months for LSB. The average price target is 31.62 USD. This implies a price increase of 4943.06% is expected in the next year compared to the current price of 0.627.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
80.00%
LSB was analyzed by 5 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about LSB.
In the previous month the buy percentage consensus was at a similar level.
Only 5 analysts analyzed LSB. So this is just the average opinion of a couple of analysts.
Recent Upgrades & Downgrades
Next Earnings Forecast Details
Next Earnings Details
Release DateDec 15, 2025
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 687.201M | 573.418M -16.56% | 614.962M 7.24% | 1.403B 128.14% | 254.65M -81.85% | 279.9M 9.92% | 343.7M 22.79% | |
| EBITDA YoY % growth | -102.695M -435.67% | -246.231M -139.77% | -12.925M 94.75% | 115.14M 990.82% | N/A | N/A | N/A | |
| EBIT YoY % growth | -139.382M -24,789.71% | -288.417M -106.92% | -49.577M 82.81% | 123.13M 348.36% | 72.822M -40.86% | 92.534M 27.07% | 140.52M 51.86% | |
| Operating Margin | -20.28% | -50.30% | -8.06% | 8.78% | 28.60% | 33.06% | 40.88% | |
| EPS YoY % growth | N/A | N/A | N/A 45.90% | 1.02 105.67% | N/A | N/A | N/A |
All data in CNY
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in CNY
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
-29.50%
Revenue Next 5 Year
-19.01%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
LAKESHORE BIOPHARMA CO LTD / LSB Forecast FAQ
What do analysts expect the price target to be for LAKESHORE BIOPHARMA CO LTD (LSB)?
5 analysts have analysed LSB and the average price target is 31.62 USD. This implies a price increase of 4943.06% is expected in the next year compared to the current price of 0.627.
Can you provide the upcoming earnings date for LAKESHORE BIOPHARMA CO LTD?
LAKESHORE BIOPHARMA CO LTD (LSB) will report earnings on 2025-12-15.
What is the consensus rating for LAKESHORE BIOPHARMA CO LTD (LSB) stock?
The consensus rating for LAKESHORE BIOPHARMA CO LTD (LSB) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.